METABOLIC ABNORMALITIES

Clinical trials for METABOLIC ABNORMALITIES explained in plain language.

Never miss a new study

Get alerted when new METABOLIC ABNORMALITIES trials appear

Sign up with your email to follow new studies for METABOLIC ABNORMALITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

Drug trial aims to tame dangerous metabolism in rare fat disorder

Disease control Terminated

This study tested an experimental drug called REGN4461 to see if it could help control serious metabolic problems in people with a rare genetic condition called familial partial lipodystrophy. The condition causes abnormal fat distribution and often leads to dangerously high bloo…

Matched conditions: METABOLIC ABNORMALITIES

Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

METABOLIC ABNORMALITIES

Get alerted when new METABOLIC ABNORMALITIES trials appear

Drug trial aims to tame dangerous metabolism in rare fat disorder